Target intelligence / Profile preview

AceI efflux transporter (AceI)

Target
AceI
Molecular classification
Transporter, Multidrug efflux pump, PACE family (Proteobacterial antimicrobial compound efflux family), Membrane protein
01

Overview

The AceI efflux transporter is a membrane protein originally identified in Acinetobacter baumannii that functions as the prototype of the proteobacterial antimicrobial compound efflux (PACE) family of transporters. It actively exports a range of antiseptics (notably chlorhexidine, benzalkonium, dequalinium, proflavine, and acriflavine), as well as naturally occurring short-chain diamines such as cadaverine and putrescine, using an electrochemical proton gradient as the energy source. The AceI gene is induced in response to the presence of these substrates, providing bacteria with adaptive resistance and substantially contributing to clinical challenges in treating infections by conferring multidrug resistance. AceI homologs are widespread across Proteobacteria, defining a new family of efflux pumps distinct from previously known multidrug transporter families[2][3][5][6][7].

Other names
Acinetobacter chlorhexidine efflux proteinPACE transporter (as a member of the family)Proteobacterial antimicrobial compound efflux family transporter
02

Mechanism of action

Active efflux of antibacterial and biocidal agents, reducing their intracellular concentration; Proton gradient-driven antiport (uses proton motive force to transport substrates out of the cell); Direct binding and transport of specific substrates

03

Biological functions

Antimicrobial resistance via efflux of biocides and antisepticsEfflux of short-chain diamines (such as cadaverine, putrescine)Maintenance of cellular homeostasisProtection from toxic compounds
04

Disease associations

InfectionAntimicrobial resistance, particularly in nosocomial (hospital-acquired) settings
05

Safety considerations

Contributes to multidrug resistance in pathogenic bacteria, primarily Acinetobacter baumannii, complicating treatment of infections with common antiseptics and increasing persistence in clinical environmentsEfflux pumps are not generally therapeutic targets in themselves but inhibitors could present toxicity or selectivity concerns
06

Interacting drugs

Chlorhexidine (antiseptic/biocide)

6 more in the full profile.

07

Biomarkers

Overexpression or induction of aceI gene in clinical isolates may serve as a biomarker for chlorhexidine (and potentially other biocide) resistance

Beyond the preview

Go deeper on AceI efflux transporter (AceI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AceI efflux transporter (AceI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call